Actinium Pharmaceuticals, Inc.
ATNM· NYSE
ATNMActinium Pharmaceuticals, Inc.
Filed Aug 13, 2013 · 10-Q · 44 days after period end · 0001213900-13-004217
| Metric | Q2 2013 | Q2 2012 | Q2 2011 |
|---|---|---|---|
| Revenue | — | $0.00 | $0.00 |
| Net Income | -$2.78M | -$1.56M | — |
| EPS Diluted | -$0.13 | -$0.09 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Actinium Pharmaceuticals, Inc. · CIK 1388320 · Engraved from SEC EDGAR
ended Jun 30, 2013 · filed Aug 13, 2013 · 44 d after period end
